Dopamine agonists as genital endometriosis target therapy.
Maria I YarmolinskayaElena SuslovaNatalia TkachenkoArseniy MolotkovIgor Yu KoganPublished in: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology (2021)
PRL involvement in GE pathogenesis and more intense therapeutic impact on pain syndrome in case of combined administration of dopamine and standard hormone therapy prove cabergoline application in clinical practice.